Results 81 to 90 of about 11,689 (208)

Heterologous Covid-19 vaccines intervention effect on reactogenicity

Journal of the Pakistan Medical Association, 2023
To determine the change in the occurrence of short-term vaccine reactions on the use of heterologous Covid-19 booster, a single centre short-term study of two months duration was conducted. It was designed as an interventional study with registered clinical trial number # SLCTR/2022/008.
Wajeha, Najeeb, Palvasha, Waheed, Rehana, Khadim   +2 more
openaire   +2 more sources

Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses

Expert Review of Vaccines, 2023
Background Evidence-based reassurances addressing vaccine-related concerns are crucial to promoting primary vaccination, completion of the primary series, and booster vaccination.
Giorgia Tiozzo, Timon Louwsma, Stefan R A Konings, Gerard T Vondeling, Judith Perez Gomez, Maarten J Postma, Roel D Freriks   +6 more
doaj   +1 more source

Decoding Undesirable Inflammatory Responses of Nucleic Acid‐Delivering Lipid Nanoparticles

Advanced Science, Volume 13, Issue 33, 15 June 2026.
Lipid nanoparticles (LNPs) enable efficient nucleic acid delivery, but their immunogenicity is a double‐edged sword. This review explores LNP‐driven innate and adaptive immunity, covering lipid components, endosomal escape, and nucleic acid sensing.
Ruimin Hu, Yin Dou, Chenwen Li, Yuying Mu, Huiying Ouyang, Wenhao Shen, Jianxiang Zhang   +6 more
wiley   +1 more source

RESULTS OF A MULTICENTER CLINICAL STUDY OF A NEW COMBINATION VACCINE DTaP-HepB+Hib PRODUCTION OF THE CPA «MICROGEN» FOR IMMUNIZATION OF CHILDREN 6 MONTHS

Журнал микробиологии, эпидемиологии и иммунобиологии, 2018
Aim. The aim of the study is evaluate of reactogenicity, safety and immunogenicity of the native combined vaccine DTaP-HepB+Hib. Materials and methods. Assessment of reactogenicity, safety and immunogenicity of the drug is investigated in a multicenter ...
I. V. Feldblyum, V. V. Romanenko, A. M. Nikolaeva, K. A. Subbotina, O. Yu. Sosnina, O. A. Perminova, O. V. Belyakova, T. V. Danilina, A. E. Ershov, D. M. Trofimov, E. A. Bykova, S. V. Martirosyan, A. V. Ankudinova   +12 more
doaj   +1 more source

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India

Human Vaccines & Immunotherapeutics, 2022
Efficacy and safety data on quadrivalent influenza vaccines (QIVs) for immunization of Indian children are scarce. This phase 3, registration study evaluated the immunogenicity, safety, and tolerability of a QIV in Indian children aged 6–35 months (Group
Nijalingappa K. Kalappanavar, Apurba Ghosh, Monika Sharma, Latha Ravichandran, Nirmal Choraria, Saravanan P, Madhukar Pandey, Pradeep N, Prachee Shah, Sneha Nair, Ashfaque Shaikh, Serge van de Witte   +11 more
doaj   +1 more source

Immunogenicity and reactogenicity of vaccine boosters after Ad26.COV2.S priming

, 2022
BACKGROUND The Ad26.COV2.S vaccine, which was approved as a single-shot immunization regimen, has been shown to be effective against severe coronavirus disease 2019.
Schmitz, K.S., Huckriede, A.L.W., SWITCH Res Grp, Vries, R.D. de, Kuy, P.H.M. van der, Goorhuis, A., Kootstra, N.A., GeurtsvanKessel, C.H., Rietdijk, W.J.R., Visser, L.G., Dalm, V.A.S.H., Koopmans, M.P.G., Baarle, D. van, Garrido, H.M.G., Lafeber, M., Postma, D.F., Geers, D., Sablerolles, R.S.G.   +17 more
core   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, Volume 158, Issue 11, Page 2983-2994, 1 June 2026.
What's new? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source

A systematic review of the impact of vaccine reactogenicity on willingness to accept influenza vaccination in adults [PDF]

ObjectiveTo assess the quantity and quality of studies investigating the impact of vaccine reactogenicity, defined as local (e.g. injection-site pain, redness, swelling) and systemic (e.g.
Seale, Holly, Lister, Helen, Farquharson, Katerine, Poletti, Tiziano, Amin, Femy, Smith, Louise, Rubin, James; id_orcid   +6 more
core   +1 more source

Respiratory Syncytial Virus Under the Lens of Structure: From Prefusion Stabilization to Next‐Generation Immunotherapies

iNew Medicine, Volume 2, Issue 2, June 2026.
This illustration integrates key concepts covered in the review, including high‐risk populations, viral structure, host entry factors, the replication cycle, and licensed antibody‐based prevention strategies. ABSTRACT Respiratory syncytial virus (RSV) is a negative‐sense RNA virus belonging to the genus Orthopneumovirus within the family Pneumoviridae.
Zekai Cheng, Qianqian Wang, Jiachen Zhang, Sandra Chiu   +3 more
wiley   +1 more source

Beyond treatment response: Injection‐site reactions as part of the extended‐release buprenorphine experience

Addiction, EarlyView.
Julien Cabé, Georges Brousse
wiley   +1 more source